Flavin Financial Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.03M Sell
4,805
-26
-0.5% -$10.4K 1.09% 32
2026
Q2
$1.75M Buy
4,831
+1,068
+28% +$366K 1% 35
2026
Q1
$1.32M Sell
3,763
-21
-0.6% -$7.49K 0.89% 38
2025
Q4
$1.24M Sell
3,784
-270
-7% -$85.6K 0.85% 40
2025
Q3
$1.14M Buy
4,054
+768
+23% +$223K 0.81% 40
2025
Q2
$917K Sell
3,286
-325
-9% -$92.1K 0.89% 41
2025
Q1
$1.13M Buy
3,611
+342
+10% +$101K 1.03% 37
2024
Q4
$852K Buy
+3,269
New +$970K 0.81% 43

Other funds holding AMGN

Flavin Financial Services's AMGN Position: Q3 2026 in Review

Flavin Financial Services reduced its Amgen (AMGN) stake by 0.54% in Q3 2026, selling an estimated $10.4K and leaving 4,805 shares worth $2.03M. The position accounts for 1.09% of the portfolio, ranked #32.

Flavin Financial Services first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 1,558 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Flavin Financial Services held 4,805 shares of Amgen worth $2.03M as of Q3 2026.
  • Flavin Financial Services sold 26 Amgen shares in Q3 2026, an estimated $10.4K.
  • Amgen made up 1.09% of Flavin Financial Services's portfolio in Q3 2026, its #32 holding.
  • Flavin Financial Services first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Flavin Financial Services's 13F filing for Q3 2026, filed 21 Oct 2026.